Log in

Evotec Stock Price, Forecast & Analysis (OTCMKTS:EVTCY)

$41.31
-0.03 (-0.07 %)
(As of 11/22/2019 06:04 AM ET)
Today's Range
$41.31
Now: $41.31
$41.70
50-Day Range
$40.94
MA: $43.23
$46.37
52-Week Range
$37.45
Now: $41.31
$59.50
Volume3,956 shs
Average Volume526 shs
Market Capitalization$3.08 billion
P/E Ratio31.30
Dividend YieldN/A
Beta1.22
Evotec AG provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company operates in two segments, EVT Execute and EVT Innovate. The EVT Execute segment offers drug discovery services, such as target identification and validation, hit identification, sample management, chemistry, drug metabolism and pharmacokinetics, research informatics proteomics and metabolomics, bio-reagents, in vitro biology, in vivo pharmacology, biomarkers, and antibody platform; INDiGO, a program for accelerating the early drug candidates into the clinic stage; integrated chemistry, manufacturing, and control services; and integrated drug discovery services. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:EVTCY
CUSIPN/A
CIKN/A
Phone49-4056-0810

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$443.55 million
Cash Flow$1.83 per share
Book Value$6.73 per share

Profitability

Net Income$99.41 million

Miscellaneous

Employees2,617
Market Cap$3.08 billion
Next Earnings Date3/17/2020 (Estimated)
OptionableNot Optionable

Receive EVTCY News and Ratings via Email

Sign-up to receive the latest news and ratings for EVTCY and its competitors with MarketBeat's FREE daily newsletter.


Evotec (OTCMKTS:EVTCY) Frequently Asked Questions

What is Evotec's stock symbol?

Evotec trades on the OTCMKTS under the ticker symbol "EVTCY."

When is Evotec's next earnings date?

Evotec is scheduled to release their next quarterly earnings announcement on Tuesday, March 17th 2020. View Earnings Estimates for Evotec.

What is the consensus analysts' recommendation for Evotec?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evotec in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evotec.

Has Evotec been receiving favorable news coverage?

News stories about EVTCY stock have been trending negative on Friday, InfoTrie Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Evotec earned a media sentiment score of -2.5 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Evotec.

Who are some of Evotec's key competitors?

What other stocks do shareholders of Evotec own?

Who are Evotec's key executives?

Evotec's management team includes the folowing people:
  • Dr. Werner Lanthaler, CEO & Member of Management Board (Age 51)
  • Mr. Enno Spillner, CFO & Member of Management Board (Age 49)
  • Dr. Cord Dohrmann, Chief Scientific Officer & Member of Management Board (Age 55)
  • Dr. Craig Johnstone, COO & Member of Management Board
  • Ms. Anja Bosler, Principal Accounting Officer and Sr. VP of Group Accounting

How do I buy shares of Evotec?

Shares of EVTCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Evotec's stock price today?

One share of EVTCY stock can currently be purchased for approximately $41.31.

How big of a company is Evotec?

Evotec has a market capitalization of $3.08 billion and generates $443.55 million in revenue each year. The company earns $99.41 million in net income (profit) each year or $1.32 on an earnings per share basis. Evotec employs 2,617 workers across the globe.View Additional Information About Evotec.

What is Evotec's official website?

The official website for Evotec is http://www.evotec.com/.

How can I contact Evotec?

Evotec's mailing address is Manfred Eigen Campus Essener Bogen 7, Hamburg 2M, 22419. The company can be reached via phone at 49-4056-0810 or via email at [email protected]


MarketBeat Community Rating for Evotec (OTCMKTS EVTCY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  149 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  293
MarketBeat's community ratings are surveys of what our community members think about Evotec and other stocks. Vote "Outperform" if you believe EVTCY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVTCY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel